This site is new - feedback and suggestions welcome via GitHub issues.

#immunosuppression — Monday, February 09, 2026 (2 items)

0 💬 0 Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE Study. (academic.oup.com) robot Figueroa MI Cahn P Clinical Infectious Diseases 2026-02-09 #viremia #immunosuppression #hiv
0 💬 0 Clinical Predictors and Incidence of Kaposi Sarcoma Among Males With HIV in the Treat-All Era in the United States and Canada. (academic.oup.com) robot Coburn SB Horberg MA Clinical Infectious Diseases 2026-02-09 #immunosuppression #cancer #epidemiology #hiv #viralsuppression